Fraud Blocker

The Rise of Heroin Use in the U.S.

Written by: Content Marketing Team

Clinically Reviewed By: Donnita Smart, LCDC

Quick Summary

Heroin use and heroin-related deaths in the United States rose sharply through the 2010s, peaked around 2016, and have declined as illicitly manufactured fentanyl has displaced heroin in the drug supply. The story is not over. Fentanyl is now involved in most overdose deaths that were once attributed to heroin alone, and treatment needs remain urgent. Here is what the most current CDC and NIDA data show.

Key Takeaways

  • Heroin overdose deaths in the U.S. rose from 3,036 in 2010 to a peak of 15,469 in 2016 (NIDA).
  • Heroin deaths declined to about 3,984 in 2023 as fentanyl displaced heroin in the supply (NIDA).
  • About 80 percent of heroin-involved deaths in 2022 and 2023 also involved illicitly manufactured fentanyl.
  • The 2024 CDC data showed a roughly 27 percent overall drop in drug overdose deaths, driven mostly by fewer fentanyl deaths.
  • Heroin use disorder is treatable, and FDA-approved medications dramatically reduce overdose risk.

Heroin use in the United States has played a significant role in the opioid crisis in America, which has been one of the defining public health stories of the last decade. The shape of that story has changed sharply in just the last few years as illicitly manufactured fentanyl reshaped the drug supply. Understanding what is happening now matters for families, communities, and anyone working in or affected by behavioral health.

The Rise: 2010 to 2016

According to the CDC’s Drug Overdose Deaths brief, heroin-involved overdose deaths in the U.S. rose from about 3,036 in 2010 to a peak of 15,469 in 2016. The increase was driven by multiple factors, including prescription opioid restrictions that tightened access following the early 2010s, growing demand for cheaper alternatives, and an expanding heroin supply, particularly across the eastern half of the country.

The Shift: Fentanyl Replaces Heroin in the Supply

Beginning around 2014 and accelerating through the late 2010s, illicitly manufactured fentanyl began appearing in heroin supplies and eventually replacing heroin altogether in many markets. Fentanyl is far more potent than heroin and is cheaper and easier to traffic. By 2022, the National Institute on Drug Abuse reported that approximately 80 percent of heroin-involved deaths also involved fentanyl.

Where Things Stand Now

The CDC reported a roughly 27 percent decline in total U.S. drug overdose deaths from 2023 to 2024, the largest single-year drop ever recorded. Heroin-involved deaths declined to about 3,984 in 2023 from their 2016 peak. The decline reflects fentanyl displacing heroin in the supply and a combination of expanded naloxone access, treatment availability, and shifts in use patterns.

This is good news, but it does not mean the problem is over. Drug overdose remains the leading cause of death for U.S. adults aged 18 to 44. Deaths involving stimulants like methamphetamine have risen even as opioid deaths have fallen, and many people who developed an opioid use disorder during the rise of heroin still need treatment today.

We Accept Most Insurance

We’re here to make treatment as accessible and affordable as possible — and are in network with many insurance providers. Not sure about your coverage? We can help.

What Heroin Does to the Body

Heroin is a fast-acting opioid that binds to opioid receptors in the brain, producing intense euphoria followed by sedation. Repeated use changes brain chemistry, builds tolerance, and creates physical dependence. Long-term effects include increased risk of overdose, infectious diseases from injection use, collapsed veins, infections of the heart lining, liver and kidney disease, and a range of mental health complications.

Treatment Works

The most effective treatment for heroin use disorder pairs FDA-approved medications (methadone, buprenorphine, or naltrexone) with counseling and recovery support. Methadone and buprenorphine cut overdose death risk roughly in half compared to no medication treatment. SAMHSA’s treatment locator can help find programs.

If You Are Worried About a Loved One

A clinical assessment is the right starting point. Common signs of heroin use can include pinpoint pupils, drowsiness, drug paraphernalia, secrecy, withdrawal from usual activities, and changes in physical health. If overdose is suspected, call 911 immediately and administer naloxone if available. The admissions team at Discovery Point Retreat can talk through what an assessment involves and what options exist.

If heroin has taken hold in your life or a loved one’s, our heroin addiction treatment program in Texas explains what medically supervised detox and residential care involve.

References

  1. National Institute on Drug Abuse. Drug overdose death rates. Accessed June 8, 2026. nida.nih.gov.
  2. Centers for Disease Control and Prevention, NCHS. Drug overdose deaths in the United States, 2023-2024. cdc.gov.
  3. Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment. BMJ. 2017;357:j1550. Full text.

Resources

  • 988 Suicide and Crisis Lifeline. Call or text 988, or chat at 988lifeline.org. Free, confidential support 24/7.
  • SAMHSA National Helpline. Call 1-800-662-HELP (4357) or visit the SAMHSA National Helpline page for free, confidential referrals to local treatment.
  • 911. For any medical emergency, including suspected overdose, call 911 immediately. If naloxone is available for a suspected opioid overdose, administer it according to the package instructions while waiting for help.

This article is general education and is not medical advice. It does not establish a clinician-patient relationship and is not a substitute for an individual assessment by a qualified mental health or addiction treatment professional.

author avatar
Reviewed By: Donnita Smart, LCDC Executive Director - Ennis
Donnita Smart is the Executive Director of Discovery Point Retreat with over a decade of leadership experience in addiction treatment and recovery services. She holds a Bachelor of Science in Social Work from the University of North Texas at Dallas and is a Licensed Chemical Dependency Counselor, with a proven track record in managing multi-site programs, regulatory compliance, and strategic growth. Donnita leads with compassion, accountability, and collaboration, driving programs that support lasting recovery for individuals and families.